Procter & Gamble Health Limited Stock Price

BSE:500126 Community·₹96.8b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

500126 Share Price Performance

₹5,833.70

741.15 (14.55%)

₹5,833.70

741.15 (14.55%)

₹5,833.70

Sat, 22 Nov 25

Share Pricen/a

500126 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Outstanding track record with flawless balance sheet.

1 Risk

2 Rewards

View Full Analysis

Procter & Gamble Health Limited Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: 184.83
: 73.21%
: 23.89%
: 0%

View Full Analysis

About 500126

Founded: 1967
Employees: 1326
CEO: Milind Thatte
WebsiteView website: www.pghealthindia.com

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemical products in India and internationally. The company offers over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. Procter & Gamble Health Limited was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India B.V.